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1. INTRODUCTION 
The bacterial protein elongation factors EF-Tu, 
EF-Ts and EF-G [l] are thought to have corre- 
sponding protein activities in eukaryotic cells now 
usually named EF-la, EF- l/Z? and EF-2, respec- 
tively. Preparations of EF-la, the factor that car- 
ries aminoacyl-tRNA to the ribosome, have been 
obtained in various degrees of purity and activity 
from pig liver [2], rabbit reticulocytes [3], Artemia 
salina (brine shrimp) [4], yeast [5] and the fungus 
Mucor (61. 
In this laboratory, we have recently begun an in- 
vestigation of possible changes occurring in cellu- 
lar enzymes during ageing [7-91, with particular 
reference to the enzymes involved in the transla- 
tional apparatus. EF-Tu is a major protein in E. 
coli [lo] as is EF-la in rabbit reticulocytes [ 111. In- 
terestingly, a decrease in the specific activity of 
EF-la with age has been reported for Turbatrix 
aceti [ 121 and for rat liver and brain [ 131. Whether 
this change in specific activity is concomitant with 
a change in rate of synthesis or degradation or 
modification is as yet unknown. We are employing 
a combination of two-dimensional gel electropho- 
resis, SDS-PAGE and immunoblotting techniques 
to detect any alterations in the size or charge of 
EF-lar which may occur in this respect [141. 
Here we report the localisation of EF- 1 (Y on two- 
dimensional gels using immunoblotting and the 
correlation of this information with currently 
available catalogues of mouse and human proteins 
[ 15,161. 
Immunoblotting Protein cataloguing 
2. MATERIALS AND METHODS 
Friend leukemia cells were grown in suspension 
in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 10% calf serum and antibiotics (pen- 
icillin 100 IU/ml; streptomycin 50 PgIml). The 
procedure for labelling with [35S]methionine has 
been described [171. 
Mouse liver homogenates were treated with 
DNase and RNAase, lyophilized and dissolved in 
dissociation buffer [ 181. Non-equilibrium pH gra- 
dient gel electrophoresis (NEPHGE) was used as 
the first dimension of the two dimensional gel elec- 
trophoresis technique, which has been described in 
detail elsewhere [18,19]. Gels were processed for 
fluorography according to Laskey and Mills [20] 
and exposed to Kodak X-omat RP X-ray film. 
Highly purified Artemia salina EF-la and rabbit 
reticulocyte EF-la were generously provided by 
Dr. W. Moller’s group (Leiden) and Dr. W. Mer- 
rick’s group (Cleveland), respectively. 
2.1. Antibody production 
Purified Artemia salina EF-la in 20 mM Tris- 
HCl (pH 7.5) 10 mM KCl, 10% (v/v) glycerol was 
emulsified in an equal volume of complete 
Freunds adjuvant and injected intramuscularly 
into a 3 month old female rabbit. Two mg of pro- 
tein factor were injected at 0 and 3 weeks. Periodic 
bleedings revealed a positive response by week 4. 
The rabbit was sacrificed on day 60. 
The IgG fraction was purified on protein A- 
Sepharose CL-4B (Pharmacia Fine Chemicals, 
Uppsala) according to Ey et al. 1211. 
332 
Published by Elsevier Biomedical Press 
00145793/82/0000-00000/$2.75 0 1982 Federation of European Biochemical Societies 
Volume 145, number 2 FEBS LETTERS August 1982 
2.2. Immunoblotting 3. RESULTS AND DISCUSSION 
Slab gel electrophoresis was conducted by use of 
the SDS-PAGE system of Laemmli [22]. Upon 
completion of the electrophoretic run, protein was 
transferred to nitrocellulose sheets essentially by 
the method of Towbin et al. [23]. Slab gels (8 cm 
wide x 5 cm long for one-dimensional SDS, 14 cm 
x 15 cm for two-dimensional gels) were placed 
onto wetted nitrocellulose paper and then covered 
with Whatman 3 MM paper and scouring pads on 
each side. The sandwich was placed between two 
1 cm plastic sheets of an electrophoretic gel de- 
stainer. The entire assembly was slotted firmly into 
the electrode chamber. The chamber was filled 
with electrode buffer (25 mM Tris-base, 192 mM 
glycine, 25% methanol at pH 8.3) and electropho- 
resis was carried out at 20 V, 300 mA for 6 h with 
the anode on the nitrocellulose side of the sand- 
wich. The temperature was maintained between 
0-4°C. The nitrocellulose paper was stained with 
amido black (0.1% in 45% methanol and 10% ace- 
tic acid), destained (90% methanol and 2% acetic 
acid) and stored in water. If the blotted nitro- 
cellulose papers were to be autoradiographed, they 
were dried between sheets of Whatman 3 MM fil- 
ter paper and exposed to Kodak X-omat RP X-ray 
film at - 70°C. After autoradiography, the sheets 
were re-wetted in buffer 1 and processed for anti- 
body binding as described below. The blots were 
incubated with 3% bovine serum albumin in saline 
(0.9% NaCl, 10 mM Tris-HCl, pH 7.4) for 1 h at 
37°C and rinsed twice with buffer 1 (0.2% SDS, 
0.5% Triton X-100, 0.5% BSA and 0.01% NaN3 in 
saline). 
Functionally active Artemia salina EF-la was 
co-run on a two-dimensional gel with a total pro- 
tein sample extracted from Friend leukemia cells, 
radioactively labelled with [3sS]methionine (tig.1). 
The high purity of the Artemia salina EF-la is evi- 
dent from the silver staining of the gel shown in 
Iig.lA. The amount of Friend leukemia cell pro- 
teins applied to the gel is too small to be revealed 
by the silver stain. The location of proteins in the 
extract of Friend leukemia cells is shown in the 
autoradiogram of tig.lB. In this way, the Artemia 
salina EF-la was used as a eukaryotic EF-la 
probe to attempt o locate the corresponding mam- 
malian factor. The position of Artemia salina EF- 
la as seen in fig.1, corresponds to NEPHGE 12 in 
current human protein catalogues [15] and 
NEPHGE 13 in current mouse kidney protein cat- 
alogues [16]. The M, estimated from SDS-PAGE 
(not shown) is approximately 53 000, which is in 
good agreement with estimates of the Mr for EF- 
la from other sources [2,3,6,11]. From the 
NEPHGE results, the isoelectric point of EF-la 
under the non-equilibrium conditions employed 
lies between pH 9 and 9.5. 
Antibodies and purified IgGs were diluted 1:200 
in buffer 1 and were incubated together with the 
blots with gentle shaking at room temperature for 
12 h. The blots were washed in buffer 1 for 30 min 
with 5 changes. The second antibody, swine anti- 
rabbit immunoglobins fluorescein isothiocyanate 
(FITC) labelled; DAK0 (Copenhagen) was di- 
luted 1:200 in buffer 1 and incubated with the 
blots for 4 h after which the blots were washed in 
buffer 1 for 30 min with 5 changes. The blots were 
photographed under UV light using a UV filter 
(Kodak wratten No. 2A). 
To determine the location of mouse liver EF- la, 
unlabelled mouse liver total protein extract was co- 
run on a two dimensional gel with a small amount 
of [35S]methionine labelled Friend leukemia cell 
protein as marker and the separated proteins then 
blotted electrophoretically onto a nitrocellulose 
sheet. The nitrocellulose sheet was stained, dried 
and autoradiographed to give the result shown in 
fig2A. A comparison of tig2A and fig. 1B gives 
evidence of the high efficiency and reproducibility 
of the protein transfer on blotting. 
After autoradiography, the nitrocellulose sheet 
was processed for antibody binding as described in 
Materials and Methods. The relevant portion of 
the stained nitrocellulose paper is shown both be- 
fore (fig2B) and after (fig.2C) treatment with the 
FITC labelled, second antibody. This confirms the 
location of mouse liver EF-la as NEPHGE 12 or 
NEPHGE 13 in human and mouse kidney cata- 
logues, respectively. 
2.3. Silver staining 
Gels for silver staining were processed according 
to Morrisey [24]. 
Two other polypeptides give a weak antibody 
reaction (indicated by small arrows in tig.2A). 
Whether these are degradation products of EF-lcw 
is under investigation, but it appears that they may 
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Fig. 1. NEPHGE of highly purified Artemia salina EF- la 
as revealed by silver staining (IA). [%]methionine 
Friend leukemia proteins have been co-run as marker 
and are revealed by fluorography (1B) after the silver 
staining step. 500 ng of purified Artemia salina EF-la 
was applied to the gel. The Friend leukemia proteins are 
extracted from cells labelled to a high specific activity 
with [%]methionine [ 171. Approximately 500 000 tri- 
chloroacetic acid precipitable cpm were loaded. The ar- 
row indicates the position of EF-la after superimposi- 
tion of the fluorogram over the silver stained gel. 
Comparison of IA and 1B with protein catalogues desig- 
nates EF-lcu as NEPHGE 12 on human catalogues 1151 
and as NEPHGE 13 on mouse kidney catalogues [ 161. 
be associated with the heterogeneity of the liver 
since they do not occur in identical gels loaded 
with unlabelled Friend leukemia protein. 
- NEPHOE 
Fig.2. NEPHGE of mouse liver total proteins co-run 
with [%]methionine labelled Friend leukemia proteins 
as marker. The proteins have been blotted onto a nitro- 
cellulose sheet and autoradiographed to give the result 
shown in tig2A. Only the area shown in fig.2A by the 
thin lined rectangle containing the major antibody bind- 
ing spot is reproduced from the amido black stained 
sheet o give lig2B. Fig.2C shows the same area as in 2B 
but after FITC labelled antibody binding. The large ar- 
rows in tig.ZA, B and C show the major binding spot. 
Weak binding spots are shown by the small arrows 
in fig.ZA. 
In further characterization and search for simi- 
lar properties of eukaryotic EF- 1 (Y and prokaryotic 
EF-Tu, we have used an immunocross-reactivity 
test, the results of which are shown in lig.3. For 
this test, we raised antibody to a sample of Artemia 
safina EF-la. Using one-dimensional gel electro- 
phoresis (fig.3), we observed that anti-Artemia sali- 
na EF-lo showed strong cross-reactivity with 
mouse liver cell extract at the appropriate molecu- 
lar weight region, and gave a strong cross-reaction 
with one band of the rabbit reticulocyte EF-la 
sample from W. Merrick’s group. In addition, 
there was a weak cross-reaction with protein from 
a yeast cell extract but none with E. coli EF-Tu. In 
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Fig.3. Cross-reactivity of antibodies raised against Ar- 
temia salina EF-la with EF-la from other sources. 
Lanes a-e show proteins after blotting onto a nitro- 
cellulose sheet (upper) and after FITC-labelled anti- 
body binding (lower). The lanes shown: (a) purified Ar- 
temia salina EF-lol; (b) yeast total protein extract; (c) 
mouse liver total protein extract; (d) purified rabbit 
reticulocyte EF-lol; and (e) E. coli EF-Tu. 
support of the lack of cross-reactivity with the pro- 
karyotic EF-Tu, we did not observe cross-reactivity 
in a reciprocal experiment between mouse liver 
EF-Tu and anti E. coli EF-Tu (kindly provided by 
G. Schatz’s group, Basel). 
4. CONCLUSION 
We have localized mouse liver EF-lcw in two-di- 
mensional gel electrophoresis patterns and correl- 
ated the position with existing mouse protein cata- 
logues [ 161. This is a step towards the identification 
of such a component of protein biosynthesis made 
in in vitro systems. Our further aim will therefore 
be to identify mouse liver EF-lcw mRNA for the 
production of its cDNA as a probe for EF-lar gene 
organization. 
Functional characteristics of the mouse liver EF- 
la also remain to be worked out. Interestingly, we 
have found that there is conservation of antigenic 
properties among various eukaryotic EF- la prepa- 
rations. This conservation of some structural pa- 
rameters does not appear to extend from eukaryo- 
tic EF-la to its prokaryotic bacterial counterpart 
EF-Tu . 
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